Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 13, 2026
An Amdocs director sold $306K of Amdocs shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$306,369
Shares × reported transaction price
Closed at $41.46 on Nov 10, 2026, at its 52-week low, after a 28% drop over the previous 30 trading days
52-week range $41.46 (Nov 10, 2026) to $84.29 (Jan 15, 2026), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $57.59 on Sep 29, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Hortig Shimie (Officer) plans to sell ~$303K of Amdocs
Planned, from payHortig Shimie (Officer) plans to sell ~$72K of Amdocs
Planned, from payEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.